Issues related to genomic medicines Issues related to biotechnology, cell and gene therapy
2025 · 3rd Quarter (July 1 - Sep 30)
DANAHER CORPORATION
Filed by DANAHER CORPORATION.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 20, 2025
- Income
- Not reported
- Expenses
- $270,000.00
- Registrant
- DANAHER CORPORATION
- Client
- DANAHER CORPORATION
- Filing UUID
- c0fb2702-260f-492b-985c-e5ad68ce6a6b
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
General issues related to tariffs
Discussions regarding export controls
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.